TruBridge (TBRG) executive awarded 5,079 restricted stock shares

Rhea-AI Filing Summary

Harse David reported acquisition or exercise transactions in this Form 4 filing.

TruBridge, Inc. General Manager Patient Care David Harse received a grant of 5,079 shares of common stock as restricted stock compensation. The award was granted at no cash cost per share and increases his directly held position to 21,091 shares of TruBridge common stock.

The restricted stock vests in three equal annual installments of one-third each, beginning on the first anniversary of the grant date. This structure ties the value of the grant to continued service over the multi‑year vesting period.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Harse David

Role General Manager Patient Care

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,079	$0.00	--

Holdings After Transaction: Common Stock — 21,091 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 5,079 shares Grant price: $0.00 per share Shares owned after grant: 21,091 shares +1 more

4 metrics

Restricted stock grant 5,079 shares Common Stock awarded to David Harse on April 8, 2026

Grant price $0.00 per share Stated transaction price for the restricted stock award

Shares owned after grant 21,091 shares Total non-derivative TruBridge common stock directly held after transaction

Vesting schedule 3 installments Vests in three annual installments of one-third each

Key Terms

restricted stock, Section 16(b), Rule 16b-3(d)

3 terms

restricted stock financial

"Represents a grant of restricted stock that vests in three annual installments"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Section 16(b) regulatory

"This transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934"

A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.

Rule 16b-3(d) regulatory

"pursuant to Rule 16b-3(d) thereunder"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harse David

(Last) (First) (Middle)

54 ST. EMANUEL STREET

(Street)

MOBILE ALABAMA 36602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TruBridge, Inc. [ TBRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Manager Patient Care

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/08/2026		A(1)		5,079	A	$0	21,091	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock that vests in three annual installments of one-third each beginning on the first anniversary of the grant date. This transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3(d) thereunder.

Remarks:

	/s/ Christopher L. Fowler, by power of attorney	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did TruBridge (TBRG) executive David Harse report in this Form 4?

David Harse, General Manager Patient Care at TruBridge (TBRG), reported receiving 5,079 shares of common stock as a restricted stock grant. This was a compensation award, not an open-market purchase, and increased his directly held stake to 21,091 shares.

How many TruBridge (TBRG) shares were granted to David Harse and at what price?

David Harse was granted 5,079 shares of TruBridge common stock at a stated transaction price of $0.00 per share. This indicates a compensation-related award rather than a cash purchase in the open market.

How does this restricted stock grant affect David Harse’s TruBridge (TBRG) holdings?

Following the restricted stock grant of 5,079 shares, David Harse now directly holds 21,091 TruBridge shares. The Form 4 shows this updated ownership figure as his total non-derivative common stock position after the reported transaction.

What is the vesting schedule for David Harse’s TruBridge (TBRG) restricted stock?

The 5,079 TruBridge restricted shares granted to David Harse vest in three equal annual installments. One-third of the award vests on each anniversary of the grant date, tying full realization of the grant to continued service over three years.

Is David Harse’s TruBridge (TBRG) restricted stock grant exempt from Section 16(b)?

Yes. The filing notes the restricted stock grant is exempt from Section 16(b) of the Securities Exchange Act under Rule 16b-3(d). This rule provides an exemption for certain insider equity awards approved under qualifying compensation arrangements.

Was David Harse’s TruBridge (TBRG) transaction a buy or sale in the open market?

The transaction was not an open-market trade. It is labeled with code “A” as a grant or award acquisition of 5,079 restricted shares, provided as equity compensation rather than purchased or sold on the stock market.